Kurbel, Sven <br/><br/>
Selective reduction of estrogen receptor (ER) positive breast cancer occurrence by estrogen receptor modulators supports etiological distinction between ER positive and ER negative breast cancers.  [electronic resource] 

 -  Medical hypotheses  2005 
 - 1182-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0306-9877 
<br/><br/><label>Standard No.: </label>10.1016/j.mehy.2004.09.026  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Breast Neoplasms--chemistry<br/>Carcinoma, Ductal, Breast--chemistry<br/>Cell Death<br/>Cell Transformation, Neoplastic<br/>Clone Cells--drug effects<br/>Female<br/>Humans<br/>Mammary Glands, Human--chemistry<br/>Models, Biological<br/>Mosaicism<br/>Neoplasm Proteins--analysis<br/>Neoplasms, Hormone-Dependent--etiology<br/>Neoplastic Stem Cells--drug effects<br/>Receptors, Estrogen--analysis<br/>Selection, Genetic<br/>Selective Estrogen Receptor Modulators--pharmacology